Author Question: When Airbus asks readers of The Financial Times whether they would be more comfortable with two or ... (Read 16 times)

rayancarla1

  • Hero Member
  • *****
  • Posts: 571
When Airbus asks readers of The Financial Times whether they would be more comfortable with two or four engines when they are up in the air, they engage in product class positioning.
 
 Indicate whether the statement is true or false

Question 2

An example of a Q&A site is:
 A) Stumbleupon.
  B) Reddit.
  C) Quora.
  D) Compuserve.
  E) Google.



nital

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

F
When Airbus asks readers of The Financial Times whether they would be more comfortable with two or four engines when they are up in the air, it makes implicit reference to Boeing; thus engaging in competitor positioning.

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

People often find it difficult to accept the idea that bacteria can be beneficial and improve health. Lactic acid bacteria are good, and when eaten, these bacteria improve health and increase longevity. These bacteria included in foods such as yogurt.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library